# Primary Sclerosing Cholangitis
What is it
Primary sclerosing cholangitis (PSC) is a chronic, progressive disorder of the gallbladder and bile ducts. The bile ducts — the tubes that transport bile from the liver to the small intestine — become gradually narrowed and damaged. This occurs due to inflammation and scarring (fibrosis) in the bile duct walls.
The condition is called "primary" because it develops on its own, without preceding infections or other clear cause (in contrast to secondary forms, caused by for example stones or tumours). It is a rare disease: in the Netherlands, approximately 500–1000 people with PSC are estimated.
An important characteristic is that PSC occurs much more frequently in people with inflammatory bowel disease, especially ulcerative colitis. However, people with PSC can also occur without bowel disease.
Causes
The precise cause of PSC is not fully understood. Research points to a combination of factors:
- **Genetic predisposition**: certain genes make you more susceptible to the disease, although these are not the only decisive factor.
- **Immune system function**: the body's own immune system apparently damages the bile duct cells, likely through an incorrectly triggered response.
- **Gut bacteria**: studies suggest that certain bacterial metabolites from the intestines may be involved in the inflammatory response.
- **Environmental factors**: to date not precisely determined.
Most patients with PSC have been unable to identify a clear "culprit" factor. This makes it difficult to prevent.
How the disease progresses
PSC typically progresses as follows:
**Silent phase**: some patients have long periods without clear symptoms, although damage to the bile ducts is already occurring. This can last for years.
**Progressive phase**: gradually the bile ducts become increasingly narrowed. This leads to a backup of bile (cholestasis), causing toxic substances to enter the bloodstream and liver inflammation to develop. This process progresses at very different speeds in different patients.
**Consequences**: eventually this can lead to liver fibrosis (scarring in the liver tissue) and ultimately cirrhosis (end-stage liver damage). The risk of bile duct infections also increases.
**Complications**: many PSC patients also develop bowel inflammation (ulcerative colitis). PSC also increases the risk of bile duct cancer (cholangiocarcinoma) and liver cancer.
Symptoms by phase
**Early stage** (often no symptoms or vague):
- Fatigue
- Itching (sometimes severe and disturbing)
- Mild abdominal pain or discomfort
- Possible yellowing of skin/eyes (jaundice) with severe cholestasis
**Progressive stage**:
- Increasing fatigue and sometimes difficulty concentrating
- Severely itchy skin (can be very distressing)
- Nausea
- Darker urine, paler stools
- Weight loss
- Abdominal pain, especially in the upper abdomen
- Enlarged spleen (felt during examination)
**Advanced stage (cirrhosis)**:
- All previous symptoms, more severe
- Swelling of abdomen or legs
- Vomiting of blood
- Drowsiness or confusion
- Fluid accumulation in abdomen
What it means for daily life
PSC has considerable consequences that can change over the course of the disease:
**Work and exertion**: many patients with PSC report severe fatigue that does not improve with rest. This can make maintaining work difficult or impossible.
**Itching**: this symptom is experienced as the most distressing by many patients. It can disrupt nighttime sleep and complicate social situations.
**Nutrition**: some patients notice that certain foods or fat are tolerated better or worse. Meals sometimes need to be adjusted.
**Mood**: the uncertainty about progression, regular examinations, and the limitation of possibilities can cause depression and anxiety. This is important to be acknowledged and treated.
**Family and partner**: because PSC is chronic and unpredictable, relationships can come under strain.
**Medical care**: regular check-ups, blood tests, ultrasounds and (sometimes) endoscopic procedures are necessary. This requires time and energy.
**Travel**: planned or urgent hospital visits can limit travel and holiday planning.
It helps to seek contact with people in the same situation and to arrange professional support for both physical and mental strain.
Outlook
The prognosis of PSC varies greatly between individuals. This makes predictions difficult:
- Some patients have a slow progression and can function reasonably well for decades.
- Others experience faster progression, with symptoms worsening within years.
**Average estimates** from larger studies (from the 2010–2020 period) point to a median symptom-free period of 10–15 years after diagnosis, but this says little about one individual.
**Important note**: these figures are population averages. Your own disease course can be very different.
Factors that can affect the course:
- Presence of ulcerative colitis
- The extent of damage at diagnosis
- Limitation of symptoms (itching, fatigue)
- Complications such as bile duct or liver cancer
- Response to supportive treatment
**Liver transplantation** is an option for patients with end-stage liver damage (cirrhosis). This can be life-extending. However, this is a decision that must be discussed with specialists at the time when the disease state warrants it.
Frequently asked questions
**Is PSC hereditary? Will my child get it?**
PSC is not directly hereditary, but there may be a genetic susceptibility that you can pass on. This does not automatically mean a child will become ill; many other factors play a role. Screening tests of family members are not routinely recommended, unless they have symptoms.
**Can I cure or slow down PSC?**
Currently there is no medication that can completely stop PSC. There are treatments that relieve symptoms (such as itching and fatigue) and some that can slow the progression of liver damage. The duration of action varies from person to person. This requires regular monitoring and adjustments.
**Does PSC really increase my cancer risk?**
Yes. Patients with PSC have an increased risk of bile duct cancer (cholangiocarcinoma) and (to a lesser extent) liver cancer. This risk increases with longer disease duration. That is why imaging and laboratory tests are performed regularly, especially if cirrhosis develops. Early detection can make a difference.
**What should I eat, and what should I avoid?**
There is no strict diet that applies to all PSC patients. Many patients find that they tolerate high-fat foods less well. It is wise to experiment with what you yourself tolerate well. Help from a dietitian specializing in liver disease can be useful. Alcohol use is discouraged because of additional strain on the liver.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._